Join the 200th Anniversary Celebration

Special Article

“We Don't Carry That” — Failure of Pharmacies in Predominantly Nonwhite Neighborhoods to Stock Opioid Analgesics

R. Sean Morrison, M.D., Sylvan Wallenstein, Ph.D., Dana K. Natale, M.A., Richard S. Senzel, M.R.P., and Lo-Li Huang, B.A.

N Engl J Med 2000; 342:1023-1026April 6, 2000

Abstract

Background

We have observed that many black and Hispanic patients receiving palliative care at a major urban teaching hospital are unable to obtain prescribed opioids from their neighborhood pharmacies. In this study, we investigated the availability of commonly prescribed opioids in New York City pharmacies.

Methods

We surveyed a randomly selected sample of 30 percent of New York City pharmacies to obtain information about their stock of opioids. For each pharmacy, U.S. Census estimates for 1997 were used to determine the racial and ethnic composition of the neighborhood (defined as the area within a 0.4-km [0.25-mile] radius of the pharmacy) and the proportion of residents who were more than 65 years old. Data on robberies, burglaries, and arrests involving illicit drugs in 1997 were obtained for the precinct in which each pharmacy was located. We used a generalized linear model to examine the relation between the racial or ethnic composition of neighborhoods and the opioid supplies of pharmacies, while controlling for the proportion of elderly persons at the census-block level and for crime rates at the precinct level.

Results

Pharmacists representing 347 of 431 eligible pharmacies (81 percent) responded to the survey. A total of 176 pharmacies (51 percent) did not have sufficient supplies of opioids to treat patients with severe pain. Only 25 percent of pharmacies in predominantly nonwhite neighborhoods (those in which less than 40 percent of residents were white) had opioid supplies that were sufficient to treat patients in severe pain, as compared with 72 percent of pharmacies in predominantly white neighborhoods (those in which at least 80 percent of residents were white) (P<0.001).

Conclusions

Pharmacies in predominantly nonwhite neighborhoods of New York City do not stock sufficient medications to treat patients with severe pain adequately.

Media in This Article

Table 1Opioid Agents and Doses.
Table 2Adequacy of Opioid Supplies at 347 Pharmacies, According to the Racial and Ethnic Composition of the Neighborhood.
Article

Pain is one of the most common and widely feared symptoms of illness.1 Studies of diverse populations of patients have found that unrelieved pain is highly prevalent,2-17 especially among minority groups.18-20 We have observed that many of our patients, particularly those who are black or Hispanic, have substantial difficulty obtaining commonly prescribed opioids from their neighborhood pharmacies. We conducted a study to determine the availability of commonly prescribed opioids in New York City pharmacies.

Methods

We surveyed a random sample of 30 percent of pharmacies listed in the 1998 NYNEX Yellow Pages for the five boroughs of New York City21-25 in order to obtain information about their opioid stock. Using the 1998 Physicians' Desk Reference, 26 the Agency for Health Care Policy and Research (AHCPR) guidelines for the treatment of pain from cancer,27 and advice from a panel of experts in palliative care, we developed a list of commonly prescribed oral and topical opioid analgesic agents, including doses for the treatment of moderate-to-severe pain (Table 1Table 1Opioid Agents and Doses.). Opioids were divided into four categories on the basis of the AHCPR guidelines: combination products for the treatment of moderate pain, short-acting opioid tablets for dose-finding in patients with severe pain and for the treatment of breakthrough pain, short-acting opioids in liquid form for the treatment of severe pain in patients with swallowing difficulties or in those in whom precise dose adjustments are required, and long-acting opioids for the extended treatment of severe pain.

Pharmacy stock was categorized as complete, nearly complete, incomplete, or absent. We considered supplies complete if the pharmacy had in stock an agent in each of the four medication categories; nearly complete if the pharmacy had in stock sufficient medication to treat a patient in moderate or severe pain — that is, a long-acting opioid, a short-acting opioid (tablet or liquid), and an opioid combination product; incomplete if the pharmacy lacked either a long-acting or a short-acting opioid preparation; and absent if the pharmacy did not carry any opioids but did stock other prescription medications.

Research assistants contacted the pharmacists by telephone. They were assured that the information they provided would be used for research purposes only, that no record would be kept of the pharmacy's name, and that responses would be kept completely confidential. Information about the study, printed on official stationery of the Mount Sinai School of Medicine, was faxed to the individual pharmacies. Pharmacists were given the option of responding over the telephone or faxing their responses to the research office. To ensure the reliability of the results, 10 responding pharmacists from each borough of New York City were randomly selected, contacted by telephone again, and questioned about a random sample of 10 opioid agents. A comparison of these responses with the original responses yielded complete agreement in all 50 cases.

Pharmacists provided oral informed consent when they were contacted by the research assistant. The study was approved by the institutional review board of the Mount Sinai School of Medicine.

Pharmacists representing pharmacies with inadequate supplies (incomplete or absent supplies) were asked open-ended questions about why they did not carry a full stock of opioid agents. Two of us independently reviewed and classified the reasons given for inadequate supplies. There was complete agreement between the two sets of classifications.

For each of the pharmacies surveyed, we used 1997 U.S. Census block-group estimates and mapping software (MapInfo Professional, version 4.0, MapInfo Corporation) to determine the racial and ethnic composition of the neighborhood in which each pharmacy was located (defined as the area within a 0.4-km [0.25-mile] radius of the pharmacy), as well as the median household income, educational level of neighborhood residents, and proportion of persons over the age of 65 years in the neighborhood. We included the variable for age because the prevalence of terminal illness and of chronic painful conditions is higher among the elderly than among younger persons, and therefore the demand for analgesic medications may be associated with the age of the residents in a neighborhood. We chose a 0.4-km radius as the definition of a neighborhood because it represented a reasonable walking distance from a pharmacy. Since one reason for not stocking opioids may be concern about theft or drug abuse,28 we obtained 1997 data on robberies, burglaries, and arrests involving illicit drugs from the New York City Police Department for the precinct in which each of the pharmacies was located.

Because of the extreme skewness of crime rates, the data were analyzed by subdividing the rates for robbery, burglary, and illicit-drug–related arrests into four groups, which were then analyzed as unordered categorical variables. For the proportion of white residents in a neighborhood, data were divided into four categories on the basis of logical breaks in the histogram and a desire to use round numbers. A neighborhood was categorized as predominantly nonwhite if less than 40 percent of the residents were white, as mixed if 40 to 69 percent were white, as primarily white if 70 to 79 percent were white, and as predominantly white if 80 to 100 percent were white. For black, Hispanic, and Asian residents, the corresponding percentages for the four categories were less than 10 percent, 10 to 19 percent, 20 to 39 percent, and 40 percent or more. Neighborhoods could be categorized according to two or more racial or ethnic groups.

The adequacy of opioid supplies was analyzed according to the categories of racial and ethnic composition. The Cochran–Armitage test for trend was used to determine whether differences in racial composition corresponded to differences in the availability of opioids. A generalized linear model for correlated data (constructed with the Proc Genmod procedure of the SAS software package, version 6.12) was used to analyze the data on the basis of a logit-link function, with the assumption that all census blocks within a precinct were equally correlated with each other. The dependent variable was a binary measure of the adequacy of opioid stock, with adequate stock defined as complete or nearly complete supplies and inadequate stock as incomplete supplies or none. Confidence intervals were based on asymptotic theory.

Results

We identified 503 pharmacies (160 in Manhattan, 130 in Brooklyn, 114 in Queens, 72 in the Bronx, and 27 on Staten Island) from the NYNEX Yellow Pages. Seventy-two of these pharmacies were no longer in business, were duplicate establishments, were located outside the New York City limits, or did not carry prescription medications. Of the pharmacists who represented the remaining 431 pharmacies, 84 refused to participate in the study, leaving a sample of 347 (an 81 percent response rate). Seventy-six percent of the pharmacies represented by respondents were independent, as were 76 percent of the pharmacies represented by nonrespondents. There were no significant differences in opioid supplies between chain and independent pharmacies, and the pharmacists representing chain pharmacies reported no specific corporate policies with regard to stocking opioids. The pharmacies represented by nonrespondents did not differ from those represented by respondents in terms of characteristics of the neighborhood (racial or ethnic composition, median household income, or educational level of residents), characteristics of the pharmacy (independent or chain), or precinct crime rates.

Of the 347 pharmacies, 176 (51 percent) did not have opioid supplies that were sufficient to provide adequate treatment for a patient with severe pain. Thirty-five pharmacies (10 percent) had complete supplies, 136 (39 percent) had nearly complete supplies, 122 (35 percent) had incomplete supplies, and 54 (16 percent) had no opioids in stock. Although 116 of the 122 pharmacies with incomplete supplies (95 percent) had a combination product in stock that could be used for the treatment of moderate pain, only 55 (45 percent) carried a strong opioid preparation that could be used for the treatment of severe pain.

Table 2Table 2Adequacy of Opioid Supplies at 347 Pharmacies, According to the Racial and Ethnic Composition of the Neighborhood. shows the adequacy of opioid supplies according to the racial and ethnic composition of the neighborhoods in which the pharmacies were located. The tests for trend for all four categories of opioid supplies were significant (P≤0.01). Twenty-five percent of pharmacies in predominantly nonwhite neighborhoods (those in which less than 40 percent of residents were white) had adequate opioid supplies, as compared with 72 percent of pharmacies in predominantly white neighborhoods (those in which at least 80 percent of residents were white) (odds ratio for adequate supplies in predominantly nonwhite neighborhoods, 0.13; 95 percent confidence interval, 0.07 to 0.26). Sixty-six percent of pharmacies that had no supplies of opioids were in predominantly nonwhite neighborhoods.

The results of a separate analysis of each ethnic and racial group were similar. The proportion of pharmacies with adequate opioid stocks was 30 percent in predominantly black neighborhoods (those in which 40 percent or more of the residents were black) as compared with 61 percent in predominantly nonblack neighborhoods (those in which less than 10 percent of the residents were black) (odds ratio, 0.28; 95 percent confidence interval, 0.14 to 0.54), 34 percent in predominantly Hispanic neighborhoods as compared with 56 percent in predominantly non-Hispanic neighborhoods (odds ratio, 0.38; 95 percent confidence interval, 0.19 to 0.74), and 25 percent in predominantly Asian neighborhoods as compared with 54 percent in predominantly non-Asian neighborhoods (odds ratio, 0.29; 95 percent confidence interval, 0.07 to 0.99). After adjustment for rates of burglary, robbery, and illicit-drug–related arrests at the precinct level and for the percentage of residents over the age of 65 years at the census-block level, pharmacies in predominantly nonwhite neighborhoods were also significantly less likely to have adequate opioid supplies than were pharmacies in predominantly white neighborhoods (odds ratio, 0.15; 95 percent confidence interval, 0.07 to 0.31). In addition, pharmacies in neighborhoods in the highest quartile of burglary rates were less likely to have adequate opioid supplies than were pharmacies in neighborhoods in the lowest quartile of burglary rates (odds ratio, 0.29; 95 percent confidence interval, 0.12 to 0.71).

The pharmacists representing the 176 pharmacies with inadequate opioid supplies were asked why they did not have adequate supplies. Ninety-five pharmacists (54 percent) reported that they had little demand for these medications, 78 (44 percent) cited concern about disposal, 35 (20 percent) cited fear of fraud and illicit drug use that might result in investigations by the Drug Enforcement Administration, 34 (19 percent) cited fear of robbery, and 13 (7 percent) cited other reasons (e.g., problems with reimbursement by health plans and Medicaid).

Discussion

We found that more than 50 percent of a random sample of New York City pharmacies did not have adequate medication in stock to treat a person in severe pain. An analysis adjusted for age and rates of burglary, robbery, and drug-related arrests showed that pharmacies in predominantly nonwhite neighborhoods were significantly less likely to stock opioids than were pharmacies in predominantly white neighborhoods. Two thirds of the pharmacies that did not carry any opioids were in neighborhoods where the majority of the residents were nonwhites. This finding, together with reports18-20 that nonwhite patients are significantly less likely than white patients to receive prescriptions for analgesic agents recommended by the AHCPR,27 suggests that members of racial and ethnic minority groups are at substantial risk for the undertreatment of pain.

Pharmacists gave three chief reasons for having inadequate supplies of opioids: regulations with regard to disposal, illicit use, and fraud; low demand; and fear of theft. Open-ended interviews revealed that a major reason for not stocking an adequate supply of opioids, apart from low demand, was the additional paperwork required by state and federal drug-enforcement agencies, the regulatory oversight and monitoring of these medications, and fear of penalties imposed by state and federal agencies. Although this study was conducted in New York, which requires triplicate prescription forms for most opioids, pharmacists did not report that this requirement was a reason for stocking inadequate supplies of opioids. Pharmacists who reported a low demand for opioids or expressed concern about their disposal were most likely to be in predominantly nonwhite neighborhoods.

There are several limitations of this study. First, it was impossible to determine conclusively whether there were differences in pharmacy supplies across neighborhoods of differing ethnic compositions if all other variables were held constant. To the extent that other variables were held constant by means of statistical adjustment, the results suggest that large and statistically significant differences remain in pharmacies' opioid holdings among different ethnic neighborhoods. Second, this study was conducted in New York City and the results may not be generalizable to other areas.

Third, pharmacists in predominantly nonwhite neighborhoods may not have provided accurate reports of their opioid supplies over the telephone. Although we considered using “professional shoppers” to validate our results, we decided that this was an impractical strategy, given the number of pharmacies, the number of agents, and the state requirement of triplicate prescriptions. Nevertheless, we believe that our results are valid because nonrespondents did not differ from respondents with regard to neighborhood characteristics or type of pharmacy (chain or independent), and follow-up telephone calls to a random sample of the respondents showed no discrepancies between their responses and those in the original survey.

Fourth, we did not ask about all opioids but instead concentrated on those that have been recommended as appropriate first-line medications. Thus, it is possible, albeit unlikely, that some pharmacies carried opioids that are useful for the treatment of severe pain (e.g., levorphanol or methadone) but that we did not inquire about. Finally, most of the pharmacists we surveyed stated that they could order and obtain the requested medication for a patient within 72 hours. For patients in severe pain, 72 hours is an unacceptably long period of time.

Our data demonstrate that many New York City pharmacies do not stock sufficient medication to treat patients with severe pain. Furthermore, pharmacies in predominantly nonwhite neighborhoods are significantly less likely to stock adequate supplies of opioids than are pharmacies in predominantly white neighborhoods. These results suggest that nonwhite patients may be at even greater risk for the undertreatment of pain than previously reported. The problem of inadequate supplies of opioids calls for a program to educate pharmacists about the safe and appropriate use of opioid analgesics, as well as an evaluation of regulations that may act as disincentives for pharmacists to stock controlled substances.

Dr. Morrison is a Faculty Scholar with the Open Society Institute's Project on Death in America and the recipient of a Mentored Clinical Scientist Development Award (K08AG00833-01) from the National Institute on Aging.

We are indebted to Dante Tipiani and Grace Chow for assisting with the interviews and to Konheim & Ketcham, of Brooklyn, New York, for providing the census data.

Source Information

From the Hertzberg Palliative Care Institute, Department of Geriatrics and Adult Development (R.S.M., D.K.N., R.S.S., L.-L.H.), and the Department of Biomathematical Sciences (S.W.), Mount Sinai School of Medicine, New York.

Address reprint requests to Dr. Morrison at the Department of Geriatrics, Box 1070, Mount Sinai School of Medicine, One Gustave L. Levy Pl., New York, NY 10029, or at .

References

References

  1. 1

    Meier DE, Morrison RS, Cassel CK. Improving palliative care. Ann Intern Med 1997;127:225-230
    Web of Science | Medline

  2. 2

    Kelsen DP, Portenoy RK, Thaler HT, et al. Pain and depression in patients with newly diagnosed pancreas cancer. J Clin Oncol 1995;13:748-755
    Web of Science | Medline

  3. 3

    Larue F, Colleau SM, Brasseur L, Cleeland CS. Multicentre study of cancer pain and its treatment in France. BMJ 1995;310:1034-1037
    CrossRef | Web of Science | Medline

  4. 4

    Tay WK, Shaw RJ, Goh CR. A survey of symptoms in hospice patients in Singapore. Ann Acad Med Singapore 1994;23:191-196
    Medline

  5. 5

    Zenz M, Zenz T, Tryba M, Strumpf M. Severe undertreatment of cancer pain: a 3-year survey of the German situation. J Pain Symptom Manage 1995;10:187-191
    CrossRef | Web of Science | Medline

  6. 6

    Von Roenn JH, Cleeland CS, Gonin R, Hatfield AK, Pandya KJ. Physician attitudes and practice in cancer pain management: a survey from the Eastern Cooperative Oncology Group. Ann Intern Med 1993;119:121-126
    Web of Science | Medline

  7. 7

    Twycross RG, Fairfield S. Pain in far-advanced cancer. Pain 1982;14:303-310
    CrossRef | Web of Science | Medline

  8. 8

    Bernabei R, Gambassi G, Lapane K, et al. Management of pain in elderly patients with cancer. JAMA 1998;279:1877-1882[Erratum, JAMA 1999;281:136.]
    CrossRef | Web of Science | Medline

  9. 9

    Lynch EP, Lazor MA, Gellis JE, Orav J, Goldman L, Marcantonio ER. Patient experience of pain after elective noncardiac surgery. Anesth Analg 1997;85:117-123
    CrossRef | Web of Science | Medline

  10. 10

    Oates JD, Snowdon SL, Jayson DW. Failure of pain relief after surgery: attitudes of ward staff and patients to postoperative analgesia. Anaesthesia 1994;49:755-758
    CrossRef | Web of Science | Medline

  11. 11

    Cohen FL. Postsurgical pain relief: patients' status and nurses' medication choices. Pain 1980;9:265-274
    CrossRef | Web of Science | Medline

  12. 12

    Breibart W, McDonald MV, Rosenfeld B, et al. Pain in ambulatory AIDS patients. I. Pain characteristics and medical correlates. Pain 1996;68:315-321
    CrossRef | Web of Science | Medline

  13. 13

    The SUPPORT Principal Investigators. A controlled trial to improve care for seriously ill hospitalized patients: the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT). JAMA 1995;274:1591-1598[Erratum, JAMA 1996;275:1232.]
    CrossRef | Web of Science

  14. 14

    Cleeland CS, Gonin R, Hatfield AK, et al. Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 1994;330:592-596
    Full Text | Web of Science | Medline

  15. 15

    Faherty BS, Grier MR. Analgesic medication for elderly people post-surgery. Nurs Res 1984;33:369-372
    CrossRef | Web of Science | Medline

  16. 16

    Closs SJ. An exploratory analysis of nurses' provision of postoperative analgesic drugs. J Adv Nurs 1990;15:42-49
    CrossRef | Web of Science | Medline

  17. 17

    Morrison RS, Siu AL. A comparison of pain and its treatment in advanced dementia and cognitively intact patients with hip fracture. J Pain Symptom Manage (in press).

  18. 18

    Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ. Pain and treatment of pain in minority patients with cancer: the Eastern Cooperative Oncology Group Minority Outpatient Pain Study. Ann Intern Med 1997;127:813-816
    Web of Science | Medline

  19. 19

    Todd KH, Samaroo N, Hoffman JR. Ethnicity as a risk factor for inadequate emergency department analgesia. JAMA 1993;269:1537-1539
    CrossRef | Web of Science | Medline

  20. 20

    McDonald DD. Gender and ethnic stereotyping and narcotic analgesic administration. Res Nurs Health 1994;17:45-49
    CrossRef | Web of Science | Medline

  21. 21

    NYNEX Yellow Pages: Manhattan. New York: NYNEX Information Resources, 1998.

  22. 22

    NYNEX Yellow Pages: Brooklyn. New York: NYNEX Information Resources, 1998.

  23. 23

    NYNEX Yellow Pages: Staten Island. New York: NYNEX Information Resources, 1998.

  24. 24

    NYNEX Yellow Pages: Bronx. New York: NYNEX Information Resources, 1998.

  25. 25

    NYNEX Yellow Pages: Queens. New York: NYNEX Information Resources, 1998.

  26. 26

    Physicians' desk reference. 52nd ed. Montvale, N.J.: Medical Economics, 1998.

  27. 27

    Jacox A, Carr DB, Payne R, et al. Management of cancer pain. Clinical practice guideline no. 9. Rockville, Md.: Agency for Health Care Policy and Research, 1994:257. (AHCPR publication no. 94-0592.)

  28. 28

    Kanner RM, Portenoy RK. Unavailability of narcotic analgesics for ambulatory cancer patients in New York City. J Pain Symptom Manage 1986;1:187-189
    CrossRef

Citing Articles (127)

Citing Articles

  1. 1

    Salimah H. Meghani, Eeeseung Byun, Rollin M. Gallagher. (2012) Time to Take Stock: A Meta-Analysis and Systematic Review of Analgesic Treatment Disparities for Pain in the United States. Pain Medicineno-no
    CrossRef

  2. 2

    Cheryl B Mwaria. (2012) Pain Management for the Terminally Ill: The Role of Race and Religion. Journal of the Islamic Medical Association of North America 43:3,
    CrossRef

  3. 3

    April M. Young, Jennifer R. Havens, Carl G. Leukefeld. (2012) A Comparison of Rural and Urban Nonmedical Prescription Opioid Users’ Lifetime and Recent Drug Use. The American Journal of Drug and Alcohol Abuse1-8
    CrossRef

  4. 4

    Salimah H. Meghani, Rosemary C. Polomano, Raymond C. Tait, April H. Vallerand, Karen O. Anderson, Rollin M. Gallagher. (2012) Advancing a National Agenda to Eliminate Disparities in Pain Care: Directions for Health Policy, Education, Practice, and Research. Pain Medicineno-no
    CrossRef

  5. 5

    Carmen R. Green, Tamera Hart-Johnson. (2012) The Association Between Race and Neighborhood Socioeconomic Status in Younger Black and White Adults With Chronic Pain. The Journal of Pain
    CrossRef

  6. 6

    Anita Holdcroft. 2011. Pain Management Market Overview. .
    CrossRef

  7. 7

    Christina L. Bell, Meiko Kuriya, Daniel Fischberg. (2011) Pain Outcomes of Inpatient Pain and Palliative Care Consultations: Differences by Race and Diagnosis. Journal of Palliative Medicine 14:10, 1142-1148
    CrossRef

  8. 8

    Emily Russell, Michael R. Kramer, Hannah L. F. Cooper, Winifred Wilkins Thompson, Kimberly R. Jacob Arriola. (2011) Residential Racial Composition, Spatial Access to Care, and Breast Cancer Mortality among Women in Georgia. Journal of Urban Health
    CrossRef

  9. 9

    Carmen R. Green, Tamera Hart-Johnson, Deena R. Loeffler. (2011) Cancer-related chronic pain. Cancer 117:9, 1994-2003
    CrossRef

  10. 10

    Salimah H. Meghani. (2011) Corporatization of Pain Medicine: Implications for Widening Pain Care Disparities. Pain Medicine 12:4, 634-644
    CrossRef

  11. 11

    Evan Anderson, Scott Burris. (2010) Opioid Treatment Agreements Are the Answer. What Is the Question?. The American Journal of Bioethics 10:11, 15-17
    CrossRef

  12. 12

    Carmen R. Green, Tamera Hart-Johnson. (2010) Cancer Pain: An Age-Based Analysis. Pain Medicine 11:10, 1525-1536
    CrossRef

  13. 13

    Renee E. Walker, Christopher R. Keane, Jessica G. Burke. (2010) Disparities and access to healthy food in the United States: A review of food deserts literature. Health & Place 16:5, 876-884
    CrossRef

  14. 14

    Andrea J. Apter, Laura A. Garcia, Rhonda C. Boyd, Xingmei Wang, Daniel K. Bogen, Thomas Ten Have. (2010) Exposure to community violence is associated with asthma hospitalizations and emergency department visits. Journal of Allergy and Clinical Immunology 126:3, 552-557
    CrossRef

  15. 15

    Dima M. Qato, Stacy Tessler Lindau, Rena M. Conti, L. Philip Schumm, G. Caleb Alexander. (2010) Racial and ethnic disparities in cardiovascular medication use among older adults in the United States. Pharmacoepidemiology and Drug Safety 19:8, 834-842
    CrossRef

  16. 16

    Virginia Dzul-Church, Jenica W. Cimino, Shelley R. Adler, Piera Wong, Wendy G. Anderson. (2010) “I'm Sitting Here By Myself …”: Experiences of Patients with Serious Illness at an Urban Public Hospital. Journal of Palliative Medicine 13:6, 695-701
    CrossRef

  17. 17

    Jon Raphael, Joan Hester, Sam Ahmedzai, Janette Barrie, Paul Farqhuar-Smith, John Williams, Catherine Urch, Michael I. Bennett, Karen Robb, Brian Simpson, Max Pittler, Barbara Wider, Charlie Ewer-Smith, James DeCourcy, Ann Young, Christina Liossi, Renee McCullough, Dilini Rajapakse, Martin Johnson, Rui Duarte, Elizabeth Sparkes. (2010) Cancer Pain: Part 2: Physical, Interventional and Complimentary Therapies; Management in the Community; Acute, Treatment-Related and Complex Cancer Pain: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and. Pain Medicine 11:6, 872-896
    CrossRef

  18. 18

    Yuya Ise, Tatsuya Morita, Naomi Maehori, Motoharu Kutsuwa, Mitsuru Shiokawa, Yoshiyuki Kizawa. (2010) Role of the Community Pharmacy in Palliative Care: A Nationwide Survey in Japan. Journal of Palliative Medicine 13:6, 733-737
    CrossRef

  19. 19

    Mary Curry Narayan. (2010) Culture's Effects on Pain Assessment and Management. AJN, American Journal of Nursing 110:4, 38-47
    CrossRef

  20. 20

    Judith A. Paice, Betty Ferrell, Nessa Coyle, Patrick Coyne, Thomas Smith. (2010) Living and Dying in East Africa. Clinical Journal of Oncology Nursing 14:2, 161-166
    CrossRef

  21. 21

    Karen O. Anderson, Carmen R. Green, Richard Payne. (2009) Racial and Ethnic Disparities in Pain: Causes and Consequences of Unequal Care. The Journal of Pain 10:12, 1187-1204
    CrossRef

  22. 22

    John T. Chibnall, Raymond C. Tait. (2009) Long-Term Adjustment to Work-Related Low Back Pain: Associations with Socio-demographics, Claim Processes, and Post-Settlement Adjustment. Pain Medicine 10:8, 1378-1388
    CrossRef

  23. 23

    Hannah L. F. Cooper, Brian H. Bossak, Barbara Tempalski, Samuel R. Friedman, Don C. Des Jarlais. (2009) Temporal Trends in Spatial Access to Pharmacies that Sell Over-the-Counter Syringes in New York City Health Districts: Relationship to Local Racial/Ethnic Composition and Need. Journal of Urban Health 86:6, 929-945
    CrossRef

  24. 24

    Megan Crowley-Matoka, Somnath Saha, Steven K. Dobscha, Diana J. Burgess. (2009) Problems of Quality and Equity in Pain Management: Exploring the Role of Biomedical Culture. Pain Medicine 10:7, 1312-1324
    CrossRef

  25. 25

    Charisse L. Johnson, Stephanie Y. Crawford, Swu-Jane Lin, J. Warren Salmon, Miriam Mobley Smith. (2009) Neighborhood Geographical Factors and the Presence of Advanced Community Pharmacy Practice Sites in Greater Chicago. American Journal of Pharmaceutical Education 73:1, 8
    CrossRef

  26. 26

    S. L. Bernstein, L. Cabral, J. Maantay, D. Peprah, D. Lounsbury, A. Maroko, M. Murphy, D. Shelley. (2009) Disparities in Access to Over-the-Counter Nicotine Replacement Products in New York City Pharmacies. American Journal of Public Health 99:9, 1699-1704
    CrossRef

  27. 27

    Lisa R. Shugarman, Sandra L. Decker, Anita Bercovitz. (2009) Demographic and Social Characteristics and Spending at the End of Life. Journal of Pain and Symptom Management 38:1, 15-26
    CrossRef

  28. 28

    Margaret Quinn Rosenzweig, Theresa Wiehagen, Adam Brufsky, Robert Arnold. (2009) Challenges of illness in metastatic breast cancer: A low-income African American perspective. Palliative and Supportive Care 7:02, 143
    CrossRef

  29. 29

    Devi E. Nampiaparampil, Joseph X. Nampiaparampil, R. Norman Harden. (2009) Pain and Prejudice. Pain Medicine 10:4, 716-721
    CrossRef

  30. 30

    R. Lopez,, B. Goldoftas,. (2009) Urban Health and the Elderly. Reviews on Environmental Health 24:1, 47-58
    CrossRef

  31. 31

    Lida Nabati, Janet Abrahm. 2009. PAIN IN THE PALLIATIVE CARE POPULATION. , 386-391.
    CrossRef

  32. 32

    Alexander K. Smith, Craig C. Earle, Ellen P. McCarthy. (2009) Racial and Ethnic Differences in End-of-Life Care in Fee-for-Service Medicare Beneficiaries with Advanced Cancer. Journal of the American Geriatrics Society 57:1, 153-158
    CrossRef

  33. 33

    Diana Jill Burgess, Megan Crowley-Matoka, Sean Phelan, John F. Dovidio, Robert Kerns, Craig Roth, Somnath Saha, Michelle van Ryn. (2008) Patient race and physicians' decisions to prescribe opioids for chronic low back pain. Social Science & Medicine 67:11, 1852-1860
    CrossRef

  34. 34

    Roland J. Thorpe, Dwayne T. Brandon, Thomas A. LaVeist. (2008) Social context as an explanation for race disparities in hypertension: Findings from the Exploring Health Disparities in Integrated Communities (EHDIC) Study. Social Science & Medicine 67:10, 1604-1611
    CrossRef

  35. 35

    Salimah H. Meghani, Rollin M. Gallagher. (2008) Disparity vs Inequity: Toward Reconceptualization of Pain Treatment Disparities. Pain Medicine 9:5, 613-623
    CrossRef

  36. 36

    Deborah A. Cohen, Sanae Inagami, Brian Finch. (2008) The built environment and collective efficacy. Health & Place 14:2, 198-208
    CrossRef

  37. 37

    Solomon Liao, Richard J. Ackermann. (2008) Interdisciplinary End-of-Life Care in Nursing Homes. Clinical Gerontologist 31:4, 83-96
    CrossRef

  38. 38

    Shaila Quazi, Mary Eberhart, Jeanne Jacoby, Michael Heller. (2008) Are racial disparities in ED analgesia improving? Evidence from a national database. The American Journal of Emergency Medicine 26:4, 462-464
    CrossRef

  39. 39

    John A. Hermos, Michael R. Winter, Timothy C. Heeren, Ralph W. Hingson. (2008) Early Age-of-onset Drinking Predicts Prescription Drug Misuse Among Teenagers and Young Adults: Results from a National Survey. Journal of Addiction Medicine 2:1, 22-30
    CrossRef

  40. 40

    Virginia Sun, Tami Borneman, Barbara Piper, Marianna Koczywas, Betty Ferrell. (2008) Barriers to pain assessment and management in cancer survivorship. Journal of Cancer Survivorship 2:1, 65-71
    CrossRef

  41. 41

    Jonathan D. Mayer, Beth Kirlin, Colin D. Rehm, John D. Loeser. (2008) Opioid Availability in Outpatient Pharmacies in Washington State. The Clinical Journal of Pain 24:2, 120-123
    CrossRef

  42. 42

    Nessa Coyle. 2008. Pain Management in the Home: Using Cancer Patients as a Model. , 1179-1186.
    CrossRef

  43. 43

    L. Benjamin. (2008) Pain Management in Sickle Cell Disease: Palliative Care Begins at Birth?. Hematology 2008:1, 466-474
    CrossRef

  44. 44

    W. Rees Davis, Bruce D. Johnson. (2008) Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug and Alcohol Dependence 92:1-3, 267-276
    CrossRef

  45. 45

    Thomas LaVeist, Roland Thorpe, Terra Bowen-Reid, John Jackson, Tiffany Gary, Darrell Gaskin, Dorothy Browne. (2008) Exploring Health Disparities in Integrated Communities: Overview of the EHDIC Study. Journal of Urban Health 85:1, 11-21
    CrossRef

  46. 46

    James F. Cleary. (2007) The Pharmacologic Management of Cancer Pain. Journal of Palliative Medicine 10:6, 1369-1394
    CrossRef

  47. 47

    Thomas A. LaVeist, Roland J. Thorpe, GiShawn A. Mance, John Jackson. (2007) Overcoming confounding of race with socio-economic status and segregation to explore race disparities in smoking. Addiction 102, 65-70
    CrossRef

  48. 48

    Stacy M. Fischer, Angela Sauaia, Jean S. Kutner. (2007) Patient Navigation: A Culturally Competent Strategy to Address Disparities in Palliative Care. Journal of Palliative Medicine 10:5, 1023-1028
    CrossRef

  49. 49

    Andrew Rosenblum, Mark Parrino, Sidney H. Schnoll, Chunki Fong, Carleen Maxwell, Charles M. Cleland, Stephen Magura, J. David Haddox. (2007) Prescription opioid abuse among enrollees into methadone maintenance treatment. Drug and Alcohol Dependence 90:1, 64-71
    CrossRef

  50. 50

    Salimah H. Meghani, Anne Keane. (2007) Preference for Analgesic Treatment for Cancer Pain Among African Americans. Journal of Pain and Symptom Management 34:2, 136-147
    CrossRef

  51. 51

    Mary M. McKay, William M. Bannon, James Rodriguez, Kelly Taber Chasse. (2007) Understanding African American Youth HIV Knowledge. Social Work in Mental Health 5:1-2, 81-100
    CrossRef

  52. 52

    Junling Wang, Shelley I. White-Means, Meghan A. Hufstader, Genene D. Walker. (2007) The economic implications of the racial and ethnic disparities in the use of selective serotonin reuptake inhibitors*. Current Medical Research and Opinion 23:4, 853-863
    CrossRef

  53. 53

    Jennifer S. Haas, Craig C. Earle, John E. Orav, Phyllis Brawarsky, Bridget A. Neville, Dolores Acevedo-Garcia, David R. Williams. (2007) Lower Use of Hospice by Cancer Patients who Live in Minority Versus White Areas. Journal of General Internal Medicine 22:3, 396-399
    CrossRef

  54. 54

    Bill H. McCarberg. (2007) Rheumatic Diseases in the Elderly: Dealing with Rheumatic Pain in Extended Care Facilities. Rheumatic Disease Clinics of North America 33:1, 87-108
    CrossRef

  55. 55

    Ian Chen, Benjamin Goodman, Marissa Galicia-Castillo, Antonio Quidgley-Nevares, Marcia Krebs, Gayle Gliva-McConvey. (2007) The EVMS Pain Education Initiative: A Multifaceted Approach to Resident Education. The Journal of Pain 8:2, 152-160
    CrossRef

  56. 56

    Joanne Lafleur, Qayyim Said, Carrie McAdam-Marx, Kenneth Jackson, Maysam Mortazavi. (2007) Problems in Studying the Association Between Race and Pain in Outcomes Research. Journal of Pain and Palliative Care Pharmacotherapy 21:3, 57-62
    CrossRef

  57. 57

    Stephen Heishman. 2006. Pharmacodynamics. , 207-311.
    CrossRef

  58. 58

    Alexie Cintron, R. Sean Morrison. (2006) Pain and Ethnicity in the United States: A Systematic Review. Journal of Palliative Medicine 9:6, 1454-1473
    CrossRef

  59. 59

    Carmen Green, Knox H. Todd, Allen Lebovits, Michael Francis. (2006) Disparities in Pain: Ethical Issues. Pain Medicine 7:6, 530-533
    CrossRef

  60. 60

    Miriam O. Ezenwa, Suzanne Ameringer, Sandra E. Ward, Ronald C. Serlin. (2006) Racial and Ethnic Disparities in Pain Management in the United States. Journal of Nursing Scholarship 38:3, 225-233
    CrossRef

  61. 61

    J. Mark Wallace. (2006) The pharmacist’s role in managing chronic opioid therapy. Current Pain and Headache Reports 10:4, 245-252
    CrossRef

  62. 62

    Karl A. Lorenz, Lisa R. Shugarman, Joanne Lynn. (2006) Health Care Policy Issues in End-of-Life Care. Journal of Palliative Medicine 9:3, 731-748
    CrossRef

  63. 63

    Terry Altilio, Shirley Otis-Green. (2006) “Res Ipsa Loquitur” … It Speaks for Itself … Social Work—Values, Pain, and Palliative Care. Journal of Social Work in End-Of-Life & Palliative Care 1:4, 3-6
    CrossRef

  64. 64

    Robert M. Arnold. (2006) Lessons Learned. Journal of Palliative Medicine 9:1, 4-6
    CrossRef

  65. 65

    NESSA COYLE. 2006. Cancer Pain Management in the Home Setting. , 349-358.
    CrossRef

  66. 66

    Peter A. Selwyn. (2005) Palliative Care for Patient with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome. Journal of Palliative Medicine 8:6, 1248-1268
    CrossRef

  67. 67

    Lavera M. Crawley. (2005) Racial, Cultural, and Ethnic Factors Influencing End-of-Life Care. Journal of Palliative Medicine 8:supplement 1, s-58-s-69
    CrossRef

  68. 68

    Carmen R. Green, S. Khady Ndao-Brumblay, Brady West, Tamika Washington. (2005) Differences in Prescription Opioid Analgesic Availability: Comparing Minority and White Pharmacies Across Michigan. The Journal of Pain 6:10, 689-699
    CrossRef

  69. 69

    James L. Werth. (2005) Becky's Legacy: Personal and Professional Reflections on Loss and Hope. Death Studies 29:8, 687-736
    CrossRef

  70. 70

    Karin Dorell, Mary Ann Cohen. (2005) Preserving a Sense of Wonder: The Integration of an Ego–Supportive Psychodynamic Approach to Supervision in an AIDS Psychiatry Fellowship. The Journal of the American Academy of Psychoanalysis and Dynamic Psychiatry 33:3, 453-463
    CrossRef

  71. 71

    Nessa Coyle. (2005) Pain management in the home. Current Pain and Headache Reports 9:4, 231-238
    CrossRef

  72. 72

    Ted Gansler, S. Jane Henley, Kevin Stein, Eric J. Nehl, Carol Smigal, Edwin Slaughter. (2005) Sociodemographic determinants of cancer treatment health literacy. Cancer 104:3, 653-660
    CrossRef

  73. 73

    Ian Chen, James Kurz, Mark Pasanen, Charles Faselis, Mukta Panda, Lisa J. Staton, Jane O’Rorke, Madhusudan Menon, Inginia Genao, JoAnn Wood, Alex J. Mechaber, Eric Rosenberg, Tim Carey, Diane Calleson, Sam Cykert. (2005) Racial differences in opioid use for chronic nonmalignant pain. Journal of General Internal Medicine 20:7, 593-598
    CrossRef

  74. 74

    Michael W. Rabow, Suzanne L. Dibble. (2005) Ethnic Differences in Pain Among Outpatients with Terminal and End-Stage Chronic Illness. Pain Medicine 6:3, 235-241
    CrossRef

  75. 75

    Marisa Nguyen, Carlos Ugarte, Ivonne Fuller, Gregory Haas, Russell K. Portenoy. (2005) Access to Care for Chronic Pain: Racial and Ethnic Differences. The Journal of Pain 6:5, 301-314
    CrossRef

  76. 76

    Sebastiano Mercadante, Davide Girelli, Alessandra Casuccio. (2005) Problematic Discharge from Hospital for Patients Prescribed Opioids for Cancer Pain. Journal of Pain and Symptom Management 29:5, 433-434
    CrossRef

  77. 77

    April Hazard Vallerand, Susan Hasenau, Thomas Templin, Deborah Collins-Bohler. (2005) Disparities Between Black and White Patients with Cancer Pain: The Effect of Perception of Control over Pain. Pain Medicine 6:3, 242-250
    CrossRef

  78. 78

    Nathan E. Goldstein, R. Sean Morrison. (2005) Treatment of pain in older patients. Critical Reviews in Oncology/Hematology 54:2, 157-164
    CrossRef

  79. 79

    John T. Chibnall, Raymond C. Tait, Elena M. Andresen, Nortin M. Hadler. (2005) Race and socioeconomic differences in post-settlement outcomes for African American and Caucasian Workers' Compensation claimants with low back injuries. Pain 114:3, 462-472
    CrossRef

  80. 80

    Swu-Jane Lin, Stephanie Y. Crawford, J. Warren Salmon. (2005) Potential access and revealed access to pain management medications. Social Science & Medicine 60:8, 1881-1891
    CrossRef

  81. 81

    Raymond C. Tait, John T. Chibnall. (2005) Racial and Ethnic Disparities in the Evaluation and Treatment of Pain: Psychological Perspectives.. Professional Psychology: Research and Practice 36:6, 595-601
    CrossRef

  82. 82

    (2005) NEWS AND INNOVATIONS. Journal of Pain and Palliative Care Pharmacotherapy 19:2, 89-107
    CrossRef

  83. 83

    Fadia T. Shaya, Steven Blume. (2005) Prescriptions for Cyclooxygenase-2 Inhibitors and Other Nonsteroidal Anti-inflammatory Agents in a Medicaid Managed Care Population: African Americans Versus Caucasians. Pain Medicine 6:1, 11-17
    CrossRef

  84. 84

    Raymond C. Tait, John T. Chibnall, Elena M. Andresen, Nortin M. Hadler. (2004) Management of occupational back injuries: differences among African Americans and Caucasians. Pain 112:3, 389-396
    CrossRef

  85. 85

    Guadalupe R. Palos, Tito R. Mendoza, Scott B. Cantor, Lu Ann Aday, Charles S. Cleeland. (2004) Perceptions of analgesic use and side effects: what the public values in pain management. Journal of Pain and Symptom Management 28:5, 460-473
    CrossRef

  86. 86

    Nancy J. Crigger. (2004) A Review of Current Health Care Funding Models. JONA's Healthcare Law, Ethics, and Regulation 6:4, 105-113
    CrossRef

  87. 87

    David E. Weissman, Deb Gordon, Shiva Bidar-Sielaff. (2004) Cultural Aspects of Pain Management. Journal of Palliative Medicine 7:5, 715-717
    CrossRef

  88. 88

    Scott M. Fishman, Rollin M. Gallagher, Daniel B. Carr, Louis W. Sullivan. (2004) The Case for Pain Medicine. Pain Medicine 5:3, 281-286
    CrossRef

  89. 89

    HECTOR LA FOSSE, CHARLES E. SCHWARTZ, ROSA J. CARABALLO, WILLIAM GOEREN, PETER A. SELWYN. (2004) Community outreach to patients with AIDS at the end of life in the inner city: Reflections from the trenches. Palliative & Supportive Care 2:03,
    CrossRef

  90. 90

    Gilbert C. Gee, Devon C. Payne-Sturges. (2004) Environmental Health Disparities: A Framework Integrating Psychosocial and Environmental Concepts. Environmental Health Perspectives 112:17, 1645-1653
    CrossRef

  91. 91

    Russell K. Portenoy, Carlos Ugarte, Ivonne Fuller, Gregory Haas. (2004) Population-based survey of pain in the united states: Differences among white, african american, and hispanic subjects. The Journal of Pain 5:6, 317-328
    CrossRef

  92. 92

    George Rust, Wendy N. Nembhard, Michelle Nichols, Folashade Omole, Patrick Minor, Gerrie Barosso, Robert Mayberry. (2004) Racial and ethnic disparities in the provision of epidural analgesia to Georgia Medicaid beneficiaries during labor and delivery. American Journal of Obstetrics and Gynecology 191:2, 456-462
    CrossRef

  93. 93

    Nessa Coyle. (2004) In their own words: seven advanced cancer patients describe their experience with pain and the use of opioid drugs. Journal of Pain and Symptom Management 27:4, 300-309
    CrossRef

  94. 94

    Perry G. Fine. (2004) Pharmacological Management of Persistent Pain in Older Patients. The Clinical Journal of Pain 20:4, 220-226
    CrossRef

  95. 95

    DENNIS ROSS-DEGNAN, LINDA SIMONI-WASTILA, JEFFREY S. BROWN, XIAOMING GAO, CONNIE MAH, LEON E. COSLER, THOMAS FANNING, PETER GALLAGHER, CARL SALZMAN, RICHARD I. SHADER, THOMAS S. INUI, STEPHEN B. SOUMERAI. (2004) A CONTROLLED STUDY OF THE EFFECTS OF STATE SURVEILLANCE ON INDICATORS OF PROBLEMATIC AND NON-PROBLEMATIC BENZODIAZEPINE USE IN A MEDICAID POPULATION. The International Journal of Psychiatry in Medicine 34:2, 103-123
    CrossRef

  96. 96

    Jeffrey E. Cassisi, Masataka Umeda, Julie A. Deisinger, Christine Sheffer, Kenneth R. Lofland, Cheryl Jackson. (2004) Patterns of Pain Descriptor Usage in African Americans and European Americans With Chronic Pain.. Cultural Diversity & Ethnic Minority Psychology 10:1, 81-89
    CrossRef

  97. 97

    Thomas A. Laveist. (2003) Racial Segregation and Longevity among African Americans: An Individual-Level Analysis. Health Services Research 38:6p2, 1719-1734
    CrossRef

  98. 98

    J. H. Tamayo-Sarver, S. W. Hinze, R. K. Cydulka, D. W. Baker. (2003) Racial and Ethnic Disparities in Emergency Department Analgesic Prescription. American Journal of Public Health 93:12, 2067-2073
    CrossRef

  99. 99

    Robin M. Weinick. (2003) Researching Disparities: Strategies for Primary Data Collection. Academic Emergency Medicine 10:11, 1161-1168
    CrossRef

  100. 100

    David C. Cone, Lynne D. Richardson, Knox H. Todd, Joseph R. Betancourt, Robert A. Lowe. (2003) Health Care Disparities in Emergency Medicine. Academic Emergency Medicine 10:11, 1176-1183
    CrossRef

  101. 101

    Carmen R. Green, Karen O. Anderson, Tamara A. Baker, Lisa C. Campbell, Sheila Decker, Roger B. Fillingim, Donna A. Kaloukalani, Kathyrn E. Lasch, Cynthia Myers, Raymond C. Tait, Knox H. Todd, April H. Vallerand. (2003) The Unequal Burden of Pain: Confronting Racial and Ethnic Disparities in Pain. Pain Medicine 4:3, 277-294
    CrossRef

  102. 102

    Peter A. Selwyn, Mimi Rivard. (2003) Palliative Care for AIDS: Challenges and Opportunities in the Era of Highly Active Anti-Retroviral Therapy. Journal of Palliative Medicine 6:3, 475-487
    CrossRef

  103. 103

    Melanie Tervalon. (2003) Components of Culture in Health for Medical Studentsʼ Education. Academic Medicine 78:6, 570-576
    CrossRef

  104. 104

    Carmen Reneé Green, Tamara A Baker, Yuka Sato, Tamika L Washington, Edna M Smith. (2003) Race and chronic pain: a comparative study of young black and white Americans presenting for management. The Journal of Pain 4:4, 176-183
    CrossRef

  105. 105

    James Zacny, George Bigelow, Peggy Compton, Kathleen Foley, Martin Iguchi, Christine Sannerud. (2003) College on Problems of Drug Dependence taskforce on prescription opioid non-medical use and abuse: position statement. Drug and Alcohol Dependence 69:3, 215-232
    CrossRef

  106. 106

    Carmen R. Green, John R. C. Wheeler. (2003) Physician Variability in the Management of Acute Postoperative and Cancer Pain: A Quantitative Analysis of the Michigan Experience. Pain Medicine 4:1, 8-20
    CrossRef

  107. 107

    Dennis P Andrulis. (2003) Reducing Racial and Ethnic Disparities in Disease Management to Improve Health Outcomes. Disease Management & Health Outcomes 11:12, 789-800
    CrossRef

  108. 108

    Richard Payne, Eduardo Medina, James W. Hampton. (2003) Quality of life concerns in patients with breast cancer. Cancer 97:S1, 311-317
    CrossRef

  109. 109

    Amy J. Schulz, David R. Williams, Barbara A. Israel, Lora Bex Lempert. (2002) Racial and Spatial Relations as Fundamental Determinants of Health in Detroit. Milbank Quarterly 80:4, 677-707
    CrossRef

  110. 110

    M. Mezey, N. N. Dubler, E. Mitty, A. A. Brody. (2002) What Impact Do Setting and Transitions Have on the Quality of Life at the End of Life and the Quality of the Dying Process?. The Gerontologist 42:Supplement 3, 54-67
    CrossRef

  111. 111

    Richard Payne, Terrie Reid Payne, Karen S. Heller. (2002) The Harlem Palliative Care Network. Journal of Palliative Medicine 5:5, 781-792
    CrossRef

  112. 112

    Lavera M. Crawley. (2002) Palliative Care in African American Communities. Journal of Palliative Medicine 5:5, 775-779
    CrossRef

  113. 113

    Mark G. Kuczewski, Patricia Marshall. (2002) The Decision Dynamics of Clinical Research. Medical Care 40:Supplement, V-45-V-54
    CrossRef

  114. 114

    June L Dahl. (2002) Working with Regulators to Improve the Standard of Care in Pain Management. Journal of Pain and Symptom Management 24:2, 136-147
    CrossRef

  115. 115

    (2002) The Management of Persistent Pain in Older Persons. Journal of the American Geriatrics Society 50:S6, 205-224
    CrossRef

  116. 116

    Karen O. Anderson, Stephen P. Richman, Judith Hurley, Guadalupe Palos, Vicente Valero, Tito R. Mendoza, Ibrahima Gning, Charles S. Cleeland. (2002) Cancer pain management among underserved minority outpatients. Cancer 94:8, 2295-2304
    CrossRef

  117. 117

    Eric L. Krakauer, Christopher Crenner, Ken Fox. (2002) Barriers to Optimum End-of-life Care for Minority Patients. Journal of the American Geriatrics Society 50:1, 182-190
    CrossRef

  118. 118

    David B Resnik. (2001) Stocking Opioids in Community Pharmacies. Journal of Pain and Symptom Management 22:1, 537-538
    CrossRef

  119. 119

    Stefan C Weiss, Linda L Emanuel, Diane L Fairclough, Ezekiel J Emanuel. (2001) Understanding the experience of pain in terminally ill patients. The Lancet 357:9265, 1311-1315
    CrossRef

  120. 120

    David B. Brushwood. (2001) From Confrontation to Collaboration: Collegial Accountability and the Expanding Role of Pharmacists in the Management of Chronic Pain. The Journal of Law, Medicine & Ethics 28:s4, 69-93
    CrossRef

  121. 121

    Ronald M Kanner. (2001) Opioids for Severe Pain. Journal of Pain and Symptom Management 21:1, 3
    CrossRef

  122. 122

    Arnold R. Gammaitoni, Rollin M. Gallagher, Maripat Welz, Edward J. Gracely, Calvin H. Knowlton, O. Voltis-Thomas. (2000) Palliative Pharmaceutical Care: A Randomized, Prospective Study of Telephone-based Prescription and Medication Counseling Services for Treating Chronic Pain. Pain Medicine 1:4, 317-331
    CrossRef

  123. 123

    Rollin M. Gallagher, Editor-in Chief. (2000) The Pain Decade and the Public Health. Pain Medicine 1:4, 283-285
    CrossRef

  124. 124

    Kyoung-Sil Kim, Myra Glajchen, Russell K Portenoy. (2000) Unwillingness to Fill Opioid Analgesic Prescriptions by Local Pharmacies. Journal of Pain and Symptom Management 20:3, 160-162
    CrossRef

  125. 125

    (2000) “We Don't Carry That”. New England Journal of Medicine 343:6, 442-445
    Full Text

  126. 126

    Freeman, Harold P., , Payne, Richard, . (2000) Racial Injustice in Health Care. New England Journal of Medicine 342:14, 1045-1047
    Full Text

  127. 127

    &NA;. (2000) Treatment of severe pain - a black and white issue?. Inpharma Weekly &amp;NA;:1233, 6
    CrossRef

Letters

Trends: Most Viewed (Last Week)

More Trends